Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype

被引:106
作者
Bertolini, S
Cantafora, A
Averna, M
Cortese, C
Motti, C
Martini, S
Pes, G
Postiglione, A
Stefanutti, C
Blotta, I
Pisciotta, L
Rolleri, M
Langheim, S
Ghisellini, M
Rabbone, I
Calandra, S
机构
[1] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy
[2] Univ Rome, Inst Med Therapy, Rome, Italy
[3] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy
[4] Univ Sassari, Inst Clin Biochem, I-07100 Sassari, Italy
[5] Univ Padua, Dept Med Sci, Padua, Italy
[6] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy
[7] Univ Palermo, Inst Internal Med, Palermo, Italy
[8] Natl Inst Hlth, Rome, Italy
[9] Univ Genoa, Dept Internal Med, Genoa, Italy
关键词
LDL receptor gene mutations; familial hypercholesterolemia; mutation clusters; receptor phenotype and clinical expression;
D O I
10.1161/01.ATV.20.9.e41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Seventy-one mutations of the low density lipoprotein (LDL) receptor gene were identified in 282 unrelated Italian familial hypercholesterolemia (FH) heterozygotes. By extending genotype analysis to families of the index cases, we identified 12 mutation clusters and localized them in specific areas of Italy. To evaluate the impact of these mutations on the clinical expression of FH, the clusters were separated into 2 groups: receptor-defective and receptor-negative, according to the LDL receptor defect caused by each mutation. These 2 groups were comparable in terms of the patients' age, sex distribution, body mass index, arterial hypertension, and smoking status. In receptor-negative subjects, LDL cholesterol was higher (+18%) and high density lipoprotein cholesterol lower (-5%) than the values found in receptor-defective subjects. The prevalence of tendon xanthomas and coronary artery disease (CAD) was 2-fold higher in receptor-negative subjects. In patients >30 years of age in both groups, the presence of CAD was related to age, arterial hypertension, previous smoking, and LDL cholesterol level. Independent contributors to CAD in the receptor-defective subjects were male sex, arterial hypertension, and LDL cholesterol level; in the receptor-negative subjects, the first 2 variables were strong predictors of CAD, whereas the LDL cholesterol level had a lower impact than in receptor-defective subjects. Overall, in receptor-negative subjects, the risk of CAD was 2.6-fold that of receptor-defective subjects. Wide interindividual variability in LDL cholesterol levels was found in each cluster. Apolipoprotein E genotype analysis showed a lowering effect of the epsilon 2 allele and a raising effect of the epsilon 4 allele on the LDL cholesterol level in both groups; however, the apolipoprotein E genotype accounted for only 4% of the variation in LDL cholesterol. Haplotype analysis showed that all families of the major dusters shared the same intragenic haplotype cosegregating with the mutation, thus suggesting the presence of common ancestors.
引用
收藏
页码:E41 / E52
页数:12
相关论文
共 50 条
  • [21] Familial hypercholesterolemia kindred in Utah with novel C54S mutations of the LDL receptor gene
    Emi, M
    Yamaki, E
    Hirayama, T
    Katsumata, H
    Pozharov, V
    Wu, LL
    Hopkins, PN
    Williams, RR
    JAPANESE HEART JOURNAL, 1998, 39 (06): : 785 - 789
  • [22] Low density lipoprotein receptor gene mutations in patients with clinical diagnosis of familial hypercholesterolemia
    Meshkov, AN
    Stambolsky, DV
    Krapivner, SR
    Bochkov, VN
    Kukharchuk, VV
    Malyshev, PP
    KARDIOLOGIYA, 2004, 44 (09) : 58 - 61
  • [23] Spectrum of LDL receptor gene mutations in Denmark:: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia
    Jensen, HK
    Jensen, LG
    Meinertz, H
    Hansen, PS
    Gregersen, N
    Færgeman, O
    ATHEROSCLEROSIS, 1999, 146 (02) : 337 - 344
  • [24] Eight novel mutations and functional impairments of the LDL receptor in familial hypercholesterolemia in the north of Japan
    Hattori, H
    Hirayama, T
    Nobe, Y
    Nagano, M
    Kujiraoka, T
    Egashira, T
    Ishii, J
    Tsuji, M
    Emi, M
    JOURNAL OF HUMAN GENETICS, 2002, 47 (02) : 80 - 87
  • [25] Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
    Jarauta, Estibaliz
    Bea-Sanz, Ana Ma
    Marco-Benedi, Victoria
    Lamiquiz-Moneo, Itziar
    FRONTIERS IN GENETICS, 2020, 11
  • [26] Eight novel mutations and functional impairments of the LDL receptor in familial hypercholesterolemia in the north of Japan
    H. Hattori
    T. Hirayama
    Y. Nobe
    M. Nagano
    T. Kujiraoka
    T. Egashira
    J. Ishii
    M. Tsuji
    M. Emi
    Journal of Human Genetics, 2002, 47 : 80 - 87
  • [27] A de novo mutation of the LDL receptor gene as the cause of familial hypercholesterolemia identified using whole exome sequencing
    Tada, Hayato
    Hosomichi, Kazuyoshi
    Okada, Hirofumi
    Kawashiri, Masa-aki
    Nohara, Atsushi
    Inazu, Akihiro
    Tomizawa, Shigeru
    Tajima, Atsushi
    Mabuchi, Hiroshi
    Hayashi, Kenshi
    CLINICA CHIMICA ACTA, 2016, 453 : 194 - 196
  • [28] Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population
    Yu, WX
    Nohara, A
    Higashikata, T
    Lu, H
    Inazu, A
    Mabuchi, H
    ATHEROSCLEROSIS, 2002, 165 (02) : 335 - 342
  • [29] Low density lipoprotein-receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia
    Punzalan, FER
    Sy, RG
    Santos, RS
    Cutiongco, EM
    Gosiengfiao, S
    Fadriguilan, E
    George, P
    Laurie, A
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2005, 12 (05) : 276 - 283
  • [30] Screening for point mutations in the LDL receptor gene in Bulgarian patients with severe hypercholesterolemia
    Mihaylov, VA
    Horvath, AD
    Savov, AS
    Kurshelova, EF
    Paskaleva, ID
    Goudev, AR
    Stoilov, IR
    Ganev, VS
    JOURNAL OF HUMAN GENETICS, 2004, 49 (04) : 173 - 176